Rappaport Reiches Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.83M | Buy |
8,711
+228
| +3% | +$47.8K | 0.46% | 25 |
|
|
2024
Q4 | $1.51M | Sell |
8,483
-567
| -6% | -$101K | 0.39% | 30 |
|
|
2024
Q3 | $1.79M | Sell |
9,050
-175
| -2% | -$34.6K | 0.48% | 25 |
|
|
2024
Q2 | $1.58M | Sell |
9,225
-7,090
| -43% | -$1.22M | 0.47% | 28 |
|
|
2024
Q1 | $2.97M | Buy |
16,315
+7,447
| +84% | +$1.36M | 0.93% | 20 |
|
|
2023
Q4 | $1.37M | Buy |
8,868
+170
| +2% | +$26.3K | 0.5% | 25 |
|
|
2023
Q3 | $1.3M | Sell |
8,698
-282
| -3% | -$42K | 0.55% | 23 |
|
|
2023
Q2 | $1.21M | Sell |
8,980
-175
| -2% | -$23.6K | 0.51% | 29 |
|
|
2023
Q1 | $1.46M | Sell |
9,155
-241
| -3% | -$38.4K | 0.65% | 22 |
|
|
2022
Q4 | $1.52M | Sell |
9,396
-233
| -2% | -$37.7K | 0.75% | 21 |
|
|
2022
Q3 | $1.29M | Sell |
9,629
-261
| -3% | -$35K | 0.66% | 23 |
|
|
2022
Q2 | $1.51M | Sell |
9,890
-13
| -0.1% | -$1.99K | 0.76% | 18 |
|
|
2022
Q1 | $1.61M | Buy |
9,903
+1,912
| +24% | +$310K | 0.86% | 21 |
|
|
2021
Q4 | $1.08M | Buy |
7,991
+910
| +13% | +$123K | 0.93% | 19 |
|
|
2021
Q3 | $764K | Sell |
7,081
-70
| -1% | -$7.55K | 0.76% | 18 |
|
|
2021
Q2 | $805K | Buy |
+7,151
| New | +$805K | 0.85% | 18 |
|